More than 400 executives said that the decision ignored both scientific and legal precedent and that, if the ruling stood, it would create uncertainty for the pharmaceutical and biotech industries.
in Economy
Pfizer CEO and Other Drug Company Leaders Condemn Texas Abortion Pill Ruling
